GALMED PHARMACEUTICALS LTD. Proceeds from Stock Options Exercised
GALMED PHARMACEUTICALS LTD. (GLMD) reported Proceeds from Stock Options Exercised of $61.00 thousand for the 12-month period ending 2020-12-31, per its 20-F filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2023-03-29
| Period end | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|
| 2020-12-31 | $61.00K 20-F · filed 2023-03-29 | |
| 2020-06-30 | $61.00K 6-K · filed 2021-08-05 | |
| 2019-12-31 | $143.00K 20-F · filed 2022-05-02 | |
| 2019-06-30 | $95.00K 6-K · filed 2020-08-06 | |
| 2018-12-31 | $1.03M 20-F · filed 2021-03-18 | |
| 2018-06-30 | $880.00K 6-K · filed 2019-08-05 | |
| 2017-12-31 | $530.00K 20-F · filed 2020-03-12 | |
| 2017-06-30 | $247.00K 6-K · filed 2018-08-02 | |
| 2016-12-31 | $255.00K 20-F · filed 2019-03-13 | |
| 2015-12-31 | $0.00 20-F · filed 2018-03-13 | |
| 2014-12-31 | $0.00 20-F · filed 2017-03-23 |